EMG
CUE icon

ETF Managers Group’s Cue Biopharma CUE Stock Holding History

ETF Managers Group’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$48.3K Buy
+451
New +$43K ﹤0.01% 660
2022
Q4 		– Sell
-348
Closed -$23K – 559
2022
Q3 		$23K Sell
348
-25
-7% -$2.15K ﹤0.01% 686
2022
Q2 		$32K Buy
373
+52
+16% +$6.08K ﹤0.01% 727
2022
Q1 		$45K Buy
321
+1
+0.3% +$212 ﹤0.01% 660
2021
Q4 		$109K Sell
320
-44
-12% -$17K ﹤0.01% 631
2021
Q3 		$155K Buy
364
+55
+18% +$19.2K ﹤0.01% 622
2021
Q2 		$112K Hold
309
– – ﹤0.01% 620
2021
Q1 		$107K Sell
309
-182
-37% -$74.9K ﹤0.01% 634
2020
Q4 		$190K Sell
491
-60
-11% -$24K ﹤0.01% 576
2020
Q3 		$255K Buy
551
+281
+104% +$162K 0.01% 544
2020
Q2 		$189K Buy
+270
New +$196K 0.01% 560

Other funds holding CUE

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $315M AUM 54.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return